Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

NCT06364137 | Completed

• 2 other identifiers: 73203R42MH136878
• Study Type: interventional
• Target: 41
• Locations: 1 country
• Sites: 1

Brief Summary

The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Conditions

Anxiety Disorders; Mood Disorders

Outcome Measures

Primary Outcomes (1)

• PRIME-O Video Coding Score

  Assess therapeutic engagement using modified PRIME-O total score, group scores, and individual item sub-scores. Scores range from 0-40, higher scores indicate 'better' outcome.

  Weeks 1, 2, 3, 4

Secondary Outcomes (3)

• My Thoughts about Therapy - Caregiver (MTT-CG) engagement questionnaire scores

  Post-intervention (at one month)

• My Thoughts about Therapy - Youth (MTT-Y) engagement questionnaire scores

  Post-intervention (at one month)

• Attendance during Psychotherapy Sessions

  One month

Study Arms (2)

Teleo

EXPERIMENTAL

Participants in this group will under therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured.

Other: Teleo

Standard videoconferencing

ACTIVE COMPARATOR

Participants in this group will under therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured.

Other: Standard videoconferencing

Interventions

Teleo OTHER

Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.

Teleo

Standard videoconferencing OTHER

Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform

Standard videoconferencing

Eligibility Criteria

• Age: 5 Years - 14 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Receiving psychotherapy with a licensed professional on the Teleo platform
• Likely have at least 12 sessions remaining.
• Diagnosis of a mental health condition by a licensed clinician

You may not qualify if:

• Not under treatment with provider using Teleo platform

Sponsors & Collaborators

• Stanford University: lead
• National Institute of Mental Health (NIMH): collaborator
• MainSquare Co. (dba 'Teleo'): collaborator

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Anxiety Disorders; Mood Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

• David S Hong, MD

  Stanford University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor of Psychiatry and Behavioral Sciences

Study Record Dates

• First Submitted: April 8, 2024
• First Posted: April 15, 2024
• Study Start: July 1, 2024
• Primary Completion: August 15, 2025
• Study Completion: September 15, 2025
• Last Updated: September 23, 2025

Record last verified: 2025-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)